$43.81
+0.33 (+0.76%)
LTH News14 articles
EGYM-Playlist $7.5B Merger Targets Healthcare and Corporate Fitness Spend
EGYM's $7.5 billion merger with Playlist aims to tap into healthcare and corporate budgets, leveraging data and connected fitness to unlock new revenue streams beyond memberships.
SELLAS Life Sciences Shares Slide 3.9% as Dilution Concerns Weigh on Valuation
SELLAS Life Sciences shares dropped 3.9% on Monday as the latest share count of 196.6 million suggests a $2.14 billion market cap, 14% above the live feed. The biotech awaits final REGAL trial data.
SELLAS Life Sciences Stock Tumbles 14% on REGAL Trial Uncertainty
SELLAS Life Sciences shares dropped 14% on Friday amid investor caution over the REGAL Phase 3 trial timeline, testing the company's $2.2 billion market cap.
SELLAS Life Sciences Stock Jumps 12% Ahead of Key Trial Results
SELLAS Life Sciences rose 12.3% on Friday, closing at $13.19, with a market cap discrepancy of $319 million ahead of REGAL trial results.
SELLAS Life Sciences Surges 12% as Equity Value Soars $1.6B
SELLAS Life Sciences shares climbed 12.3% to $13.19, lifting estimated equity value by $1.62 billion since May. The REGAL trial's 80th event is pending.
Coca-Cola Edges Up Pre-Market as Fairlife Cyber Attack Highlights $6.2B Stake
Coca-Cola shares edged higher in premarket trading after a ransomware attack disrupted fairlife production, highlighting the company's $6.2 billion investment in the dairy brand.
SELLAS Life Sciences Soars on Heavy Short Interest Ahead of AML Trial Results
SELLAS Life Sciences (SLS) surged 6.3% to $11.19 as short interest climbed to 32.65% of float and trading volume doubled. The company amended executive severance terms and disclosed 78 of 80 events reached in its Phase 3 AML trial.
SELLAS Life Sciences Soars on Executive Severance Update
SELLAS Life Sciences (SLS) surged 12.6% to $10.33 on heavy volume after an 8-K filing revealed changes to executive severance terms. The stock's implied equity value reached $2.03 billion.
Manulife Shares Dip 6% on Q1 Earnings Miss Despite Asia Strength
Manulife Financial Corp (MFC) shares slid nearly 6% after Q1 core earnings missed estimates, even as Asia profits surged 22%. Net income doubled, but Canada and U.S. results weakened.
Primerica Beats Q1 Forecasts, Investment Sales Surge Offsets Life Insurance Dip
Primerica topped Q1 earnings estimates with $5.96 per share, driven by record investment product sales, though new life insurance policies declined 14%.
White House Considers $500M Lifeline for Spirit Airlines Amid Fuel Crisis
The White House is nearing a $500 million loan agreement for Spirit Airlines, which faces collapse due to soaring fuel prices. The administration also opposes a potential merger between United and American Airlines.
Norse Atlantic Axes LA Summer Routes Amid Fuel Price Surge, Seeks $180M Lifeline
Norse Atlantic Airways has scrapped its entire summer schedule from Los Angeles to European hubs, blaming a sharp rise in jet fuel prices. The airline simultaneously announced a $110 million rights issue and secured a $70 million bridge loan.
Quince Therapeutics Engages LifeSci for Strategic Review Amid Phase 3 Setback
Quince Therapeutics shares fell 6.6% in premarket trading after hiring LifeSci Capital to explore strategic alternatives and debt restructuring, following a failed Phase 3 trial and board resignations.
China Life Insurance Shares Dip Ahead of Key Inflation Data Release
China Life Insurance's A-shares fell 0.75% to 47.47 yuan as markets closed Friday, with investors awaiting January inflation figures due February 11. The broader Shanghai Composite declined 0.25%.